B. Timothy Walsh, MD, Chief
The Division of Clinical Therapeutics focuses on clinical research of non-psychotic psychiatric disorders on adults. This division was formed in 2007 by combining the following sub-units: Anxiety Disorders Clinic, Anxiety Genetics Unit, Biological Studies Unit, Center for Neuroinflammatory Disorders and Biobehavioral Medicine/ Lyme Disease, Clinical Psychopharmacology, Depression Evaluation Service and the Eating Disorders Research Unit.
Current investigations include treatment of unipolar and bipolar depressive disorders, of a range of anxiety disorders and eating disorders, of smoking cessation, of hypochondriasis, of psychiatric symptoms following Lyme disease, and of fatigue associated with HIV.
A variety of techniques are being applied to uncover psychological, biological, genetic, and environmental factors that contribute to the development and persistence of these serious psychiatric problems. These include brain imagining, molecular genetics, and neuropsychological assessment. Treatment trials using both medication and psychotherapy are underway in each of these areas as part of a world-renowned research program; there is no charge to research participants.